Profile data is unavailable for this security.
About the company
Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxaphylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Chlorinated Solvents, Industrial Intermediates, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.
- Revenue in INR (TTM)3.48bn
- Net income in INR42.19m
- Incorporated1990
- Employees0.00
- LocationAarey Drugs and Pharmaceuticals Ltd107, Sahakar Bhavan340/348, Narshi Natha Street, MasjidMUMBAI 400009IndiaIND
- Phone+91 2 262872900
- Fax+91 2 266313166
- Websitehttp://www.aareydrugs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofil Chemicals and Pharmaceuticals Ltd | 384.48m | 6.69m | 1.15bn | -- | 170.94 | -- | 104.21 | 2.98 | 0.4118 | 0.4118 | 23.91 | -- | -- | -- | -- | -- | -- | 2.86 | -- | 5.39 | 6.82 | 11.61 | 1.74 | 2.97 | -- | 27.03 | -- | -- | 34.19 | 19.43 | -19.76 | 3.55 | -51.09 | -- |
| Lasa Supergenerics Ltd | 1.17bn | -214.42m | 1.28bn | 89.00 | -- | -- | -- | 1.10 | -4.28 | -4.28 | 23.30 | -- | -- | -- | -- | 13,128,270.00 | -- | -2.61 | -- | -3.75 | 29.74 | 32.34 | -18.35 | -3.67 | -- | -0.949 | -- | -- | -5.51 | -12.02 | -624.41 | -- | -- | -- |
| Sotac Pharmaceuticals Ltd | 579.83m | 44.96m | 1.36bn | 89.00 | 22.04 | 8.60 | 22.20 | 2.34 | 5.58 | 5.58 | 60.69 | 14.31 | -- | -- | -- | -- | -- | -- | -- | -- | 30.90 | -- | 7.75 | -- | 0.9968 | 8.62 | 0.4806 | -- | -20.74 | -- | 56.17 | -- | -- | -- |
| Ind Swift Ltd | 4.73bn | 297.88m | 1.37bn | 1.67k | 4.63 | -- | 2.40 | 0.2904 | 5.48 | 5.48 | 87.46 | -- | -- | -- | -- | -- | -- | -1.11 | -- | -- | 43.41 | 46.03 | 6.30 | -1.95 | -- | 0.2304 | -- | -- | 3.33 | 8.72 | 230.05 | -- | 38.00 | -- |
| Aarey Drugs and Pharmaceuticals Ltd | 3.48bn | 42.19m | 1.47bn | 0.00 | 31.46 | -- | 25.67 | 0.4214 | 1.66 | 1.66 | 137.72 | -- | -- | -- | -- | -- | -- | 2.78 | -- | 5.84 | 4.17 | 3.66 | 1.21 | 1.52 | -- | 1.63 | -- | -- | -14.96 | 3.70 | -42.38 | -9.40 | 10.95 | -- |
| Krebs Biochemicals And Industries Ltd | 499.09m | -208.21m | 1.54bn | 210.00 | -- | -- | -- | 3.08 | -9.50 | -9.50 | 22.86 | -- | -- | -- | -- | 2,376,624.00 | -- | -18.88 | -- | -29.04 | 86.28 | 11.95 | -41.72 | -59.37 | -- | -3.78 | -- | -- | -12.68 | 9.07 | 44.55 | -- | 28.63 | -- |
| Bal Pharma Ltd | 3.27bn | 35.19m | 1.57bn | -- | 45.62 | -- | 11.57 | 0.4787 | 2.17 | 2.17 | 209.85 | -- | -- | -- | -- | -- | -- | 0.1785 | -- | 0.4782 | 44.02 | 43.81 | 1.08 | 0.1865 | -- | 1.34 | -- | 132.38 | 8.18 | 7.54 | -54.17 | -1.56 | 31.09 | 0.00 |
| Mangalam Drugs and Organics Ltd | 3.57bn | -169.87m | 1.61bn | 523.00 | -- | -- | -- | 0.451 | -10.74 | -10.74 | 225.21 | -- | -- | -- | -- | 6,834,930.00 | -- | 3.70 | -- | 6.50 | 26.38 | 29.07 | -4.75 | 2.87 | -- | -0.5682 | -- | -- | -17.47 | 5.91 | -93.54 | -42.32 | 11.78 | -- |
| Vaishali Pharma Ltd | 801.21m | 58.38m | 1.70bn | -- | 30.75 | -- | 26.73 | 2.12 | 5.15 | 5.15 | 68.64 | -- | -- | -- | -- | -- | -- | 3.32 | -- | 8.64 | 17.72 | 15.06 | 7.29 | 3.71 | -- | 4.37 | -- | -- | -8.12 | 0.5072 | 64.12 | 52.62 | -4.18 | -- |
